Cardiac Sympathetic Imaging With mIBG in Heart Failure

JACC: Cardiovascular Imaging

Volumn 3, Issue 1, 2010, Pages 92-100

  Carrió, Ignasi ^a   Cowie, Martin R ^b   Yamazaki, Junichi ^d   Udelson, James ^e   Camici, Paolo G ^a,c  

^a Hospital Sant Pau   (Spain)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac sympathetic imaging; heart failure; mIBG; prognosis; sudden death

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARDIOVASCULAR AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOOP DIURETIC AGENT; METOPROLOL; SPIRONOLACTONE; TECHNETIUM 99M; TETROFOSMIN TC 99M;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG UPTAKE; EVENT FREE SURVIVAL; HEART FAILURE; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; FEMALE; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RISK ASSESSMENT; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 73649130995     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.07.014     Document Type: Review

References (53)

1. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
2. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
3. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
4. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
5. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
6. Mehta P.A., Dubrey S.W., McIntyre H.F., et al. Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail 10 (2008) 1108-1116
7. Tomaselli G.F., and Zipes D.P. What causes sudden death in heart failure?. Circ Res 95 (2004) 754-763
8. Hunt S.A., Abrahams W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 46 (2005) e1-e82
9. Dickstein K., Cohen-Solal A., Filipattos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 10 (2008) 933-989
10. Komajda M., Lapuerta P., Hermans N., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26 (2005) 1653-1659
11. Ungerer M., Bohm M., Elce J.S., et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87 (1993) 454-463
12. Caldwell J.H., Link J.M., Levy W.C., et al. Evidence for pre to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 49 (2008) 234-241
13. Spyrou N., Rosen S.D., Fath-Ordoubadi F., et al. Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol 40 (2002) 1216-1224
14. Merlet P., Delforge J., Syrota A., et al. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 87 (1993) 1169-1178
15. Choudhury L., Rosen S.D., Lefroy D.C., et al. Myocardial beta adrenoceptor density in primary and secondary left ventricular hypertrophy. Eur Heart J 17 (1996) 1703-1709
16. Carrio I. Cardiac neurotransmission imaging. J Nucl Med 42 (2001) 1062-1076
17. Agostini D., Carrio I., and Verberne H.J. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging 36 (2009) 555-559
18. Estorch M., Carrio I., Berna L., Lopez-Pousa J., and Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol 2 (1995) 126-132
19. Chen J., Garcia E.V., Galt J.R., et al. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 13 (2006) 251-260
20. Dae M.W., O'Connell J.W., Botvinick E., and Chin M.C. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 30 (1995) 270-280
21. McGhie A.I., Corbett J.R., Akers M.S., et al. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 67 (1991) 236-242
22. Hartikainen J., Mustonen J., Kuikka J., et al. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 80 (1997) 273-277
23. Nakata T., Nagao K., Tsuchihashi K., et al. Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease. Am J Cardiol 78 (1996) 292-297
24. Estorch M., Flotats A., Serra-Grima R., et al. Influence of exercise rehabilitation on myocardial perfusion and sympathetic heart innervation in ischemic heart disease. Eur J Nucl Med 27 (2000) 333-339
25. Gaudino M., Giordano A., Santarelli P., et al. Immunohistochemical-scintigraphic correlation of sympathetic cardiac innervation in postischemic left ventricular aneurysms. J Nucl Cardiol 9 (2002) 601-607
26. Matsunari I., Schricke U., Bengel F.M., et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 101 (2000) 2579-2585
27. Estorch M., Narula J., Flotats A., et al. Concordance between rest MIBG and exercise tetrofosmin defects: possible use of rest MIBG imaging as a marker of reversible ischaemia. Eur J Nucl Med 28 (2001) 614-619
28. Kawai Y., Tsukamoto E., Nozaki Y., Morita K., Sakurai M., and Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 38 (2001) 1888-1894
29. Watanabe K., Takahashi T., Miyajima S., et al. Myocardial sympathetic denervation, fatty acid metabolism, and LV wall motion in vasospastic angina. J Nucl Med 43 (2002) 1476-1481
30. He Z.X., Shi R.F., Wu Y.J., et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 108 (2003) 1208-1213
31. Dilsizian V., Bateman T.M., Bergmann S.R., et al. Metabolic imaging with β-methyl-ρ-[123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation 112 (2005) 2169-2174
32. Dou K.F., Yang M.F., Yang Y.J., et al. Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med 49 (2008) 1986-1991
33. Merlet P., Valette H., Dubois-Rande J.L., et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33 (1992) 471-477
34. Merlet P., Benvenuti C., Moyse D., et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40 (1999) 917-923
35. Cohen-Solal A., Esanu Y., Logeart D., et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 2 (1999) 759-766
36. Nakata T., Miyamoto K., Doi A., et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5 (1998) 579-590
37. Wakabayashi T., Nakata T., Hashimoto A., et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 42 (2001) 1757-1767
38. Kyuma M., Nakata T., Hashimoto A., et al. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic innervation, and noncardiac disorders in patients with heart failure. J Nucl Med 45 (2004) 155-163
39. Agostini D., Verberne H.J., Burchert W., et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 35 (2008) 535-546
40. Ogita H., Shimonagata T., Fukunami M., et al. Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 86 (2001) 656-660
41. Kioka H., Yamada T., Mine T., et al. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac MIBG imaging. Heart 93 (2007) 1213-1218
42. Yamada T., Shimonagata T., Fukunami M., et al. Comparison of the prognostic value of cardiac MIBG imaging and heart rate variability in patients with chronic heart failure. A prospective study. J Am Coll Cardiol 41 (2003) 231-238
43. Verberne H.J., Brewster L.M., Somsen A., and van Eck-Smit B. Prognostic value of myocardial MIBG parameters in patients with heart failure: a systematic review. Eur Heart J 29 (2008) 1147-1159
44. Somsen G.A., van Vlies B., de Milliano P.A., et al. Increased myocardial [123-I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart 76 (1996) 218-222
45. Fukuoka S., Hayashida K., and Hirose Y. Use of MIBG myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med 24 (1997) 523-529
46. Kasama S., Toyama T., Kumakura H., et al. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved LVEF. J Am Coll Cardiol 45 (2005) 661-667
47. Gerson M.C., Craft L.L., McGuire N., et al. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by MIBG. J Nucl Cardiol 9 (2002) 608-615
48. Suwa M., Otake Y., Moriguchi A., et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. (erratum in Am Heart J 1997;134:1141). Am Heart J 133 (1997) 353-358
49. Agostini D., Belin A., Amar M.H., et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG study. J Nucl Med 41 (2000) 845-851
50. Kasama S., Toyama T., Kumakura H., et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 41 (2003) 574-581
51. Toyama T., Hoshizaki H., Seki R., et al. Efficacy of amiodarone treatment on cardiac symptom, function and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy. J Nucl Cardiol 11 (2004) 134-141
52. 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced LVEF. J Nucl Med 49 (2008) 907-914
53. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging 1 (2008) 131-140